Fludarabine treatment and transfusion-associated graft-versus-host disease [4]

Lancet

Volumn 348, Issue 9025, 1996, Pages 472-473

  Williamson, L M ^a   Wimperis, J Z ^a   Wood, M E ^a   Woodcock, B ^a   Saven, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNISONE;

B LYMPHOCYTE; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CASE REPORT; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HUMAN; IMMUNE DEFICIENCY; LETTER; MORTALITY; PANCYTOPENIA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029792989     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64563-1     Document Type: Letter

References (5)

1. CLL French Cooperative Group on Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced stage chronic lymphocytic leukaemia Lancet 347 1996 1432 1438
2. JV Linden PT Pisciotto Transfusion-associated graft-versus-host disease and blood irradiation Transfus Med Rev VI 1992 116 123
3. ZT Maung AC Wood GH Jackson Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia Br J Haematol 88 1994 649 652
4. S O'Brien H Kantarjian M Beran Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukaemia with multivariate analysis-derived prognostic model for response to treatment Blood 82 1993 1695 1700
5. LM Williamson British Committee for Standards in Haematology Blood Transfusion Task Force: guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease Transfus Med 6 1996 261 271